Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus.
We present an interesting case of recurrent paralytic ileus due to strongyloidiasis in a woman who was being treated with corticosteroids and immunosuppressants for systemic lupus erythematosus (SLE). She was also a carrier of human T-cell leukemia virus type I. She had a history of strongyloidiasis 8 years earlier. Recurrent episodes of paralytic ileus due to strongyloidiasis occurred during treatment of her SLE with corticosteroids. Ivermectin was given and improved the symptoms. This case shows that symptomatic strongyloidiasis can be induced in immunocompromised hosts by immunosuppressive therapy. It is important to rule out strongyloidiasis prior to starting immunosuppressive therapy in patients from endemic areas.
Yoshida
Hide
H
Division of Rheumatology, Department of Internal Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara 228-8555, Japan. yhide@med.kitasato-u.ac.jp
Endo
Hirahito
H
Tanaka
Sumiaki
S
Ishikawa
Akira
A
Kondo
Hirobumi
H
Nakamura
Takeshi
T
D000818:Animals; D000977:Antiparasitic Agents / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007418:Intestinal Pseudo-Obstruction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000469:parasitology*; D007559:Ivermectin / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008875:Middle Aged; D011239:Prednisolone / Q000009:adverse effects*; D011859:Radiography; D012008:Recurrence; D013321:Strongyloides / Q000302:isolation & purification; D013322:Strongyloidiasis / Q000139:chemically induced* / Q000188:drug therapy
D000977:Antiparasitic Agents; D005938:Glucocorticoids; D007559:Ivermectin; D011239:Prednisolone